Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

Go back to Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
AGENUS (NASDAQ: AGEN) Delayed: 3.00 --0 (-0%)
Previous Close $3.00    52 Week High $7.49 
Open $3.00    52 Week Low $2.61 
Day High $3.00    P/E N/A 
Day Low $3.00    EPS $-1.10 
Volume 38       

(NASDAQ: INKT) Delayed: 12.14 --0 (-0%)
Previous Close $12.14    52 Week High
Open $12.14    52 Week Low
Day High $12.14    P/E N/A 
Day Low $12.14    EPS
Volume 263